# GlaxoSmithKline Research and Development SA, en liquidation

> Swiss commercial-register record from Swiss Graph (graph.swiss), sourced
> from the Swiss Official Gazette of Commerce (SHAB/SOGC).
> Canonical profile: https://graph.swiss/companies/glaxosmithkline-research-and-development-sa-en-liquidation/1524505

## Registry facts

- UID: CHE-103.181.714
- Status: liquidation
- Legal form: limited
- Registered: 1997-12-23
- Address: route de l'Aéroport 10, WTCI
- Location: ge
- Industry (NOGA): 721001, Research and experimental development in the pharmaceutical industry
- Capital: 1'000 actions de CHF 100, nominatives

## Purpose

recherche expérimentale et autre dans le domaine pharmaceutique, biologique et biochimique, conseil dans ces domaines et exploitation des résultats de la recherche.

## Previous names

- Glaxo Wellcome Experimental Research SA
- GlaxoSmithKline Research and Development SA

## Registered officers

- Hans Hüssy — liquidateur — signature individuelle
- PricewaterhouseCoopers SA — organe de révision
- Rose-Marie Burn — signature collective à 2
- Nicolas Guex — signature collective à 2
- Terence Thorpe — signature collective à 2
- Manuel Peitsch — adm. président et délégué — signature collective à 2
- Peter Weibel — adm. président — signature collective à 2
- Allan Baxter — adm. — signature collective à 2
- STG-Coopers & Lybrand SA — organe de révision
- Rose-Marie — signature collective à 2
- Clare — signature collective à 2
- François Conquet — signature collective à 2
- Anne Danckaert — signature collective à 2
- Clive — signature collective à 2
- Marcel Poncioni — signature collective à 2
- Véronique Stofer-Leuthold — signature collective à 2

---

Machine-readable variant of https://graph.swiss/companies/glaxosmithkline-research-and-development-sa-en-liquidation/1524505: registry facts only; the HTML
profile adds the corporate network, publications and live enrichment.
Site overview for agents: https://graph.swiss/llms.txt